Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Arcus Biosciences (RCUS) over the last 8 years, with Q3 2025 value amounting to 0.23.

  • Arcus Biosciences' Asset Utilization Ratio rose 1134.06% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year increase of 1134.06%. This contributed to the annual value of 0.23 for FY2024, which is 13524.64% up from last year.
  • Arcus Biosciences' Asset Utilization Ratio amounted to 0.23 in Q3 2025, which was up 1134.06% from 0.23 recorded in Q2 2025.
  • Arcus Biosciences' Asset Utilization Ratio's 5-year high stood at 0.32 during Q4 2021, with a 5-year trough of 0.04 in Q3 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.17, with a median of 0.2 in 2024.
  • Over the last 5 years, Arcus Biosciences' Asset Utilization Ratio had its largest YoY gain of 59167.47% in 2022, and its largest YoY loss of 7360.71% in 2022.
  • Over the past 5 years, Arcus Biosciences' Asset Utilization Ratio (Quarter) stood at 0.32 in 2021, then plummeted by 73.61% to 0.08 in 2022, then rose by 23.1% to 0.1 in 2023, then surged by 105.75% to 0.21 in 2024, then rose by 11.23% to 0.23 in 2025.
  • Its last three reported values are 0.23 in Q3 2025, 0.23 for Q2 2025, and 0.12 during Q1 2025.